Management of Cognitive Difficulties After Cancer Treatments in Women Treated for Breast Cancer: Feasibility Study (Step 1 of the Cog-Stim Protocol)
NCT ID: NCT04213365
Last Updated: 2022-03-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2020-01-24
2022-02-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer
NCT06027632
Impact on Cognitive Function and Quality of Life of Adjuvant Chemotherapy in Patients Aged Over 65 Years: Application to Breast Cancer or Colon
NCT01333735
Cognitive Training and Exercise for Women With Breast Cancer and Cognitive Impairment
NCT07017530
Use of Cognitive Stimulation Software for Patients Over the Age of 70 Followed for Breast Cancer: COG-TAB-AGE Feasibility Study
NCT04261153
Improving Cognition After Cancer
NCT04049695
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
cognitive stimulation and adapted physical activity
12 weeks of cognitive stimulation sessions coupled with APA (Adapted Physical Activity) sessions.
Cognitive stimulation sessions coupled with Adapted Physical Activity sessions.
12 weeks of cognitive stimulation sessions coupled with APA (Adapted Physical Activity) sessions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive stimulation sessions coupled with Adapted Physical Activity sessions.
12 weeks of cognitive stimulation sessions coupled with APA (Adapted Physical Activity) sessions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with localized breast cancer, starting or receiving adjuvant radiotherapy , having or not receiving previous adjuvant chemotherapy, not yet having started hormone therapy,
* Patient with a cognitive complaint having a significant impact on her quality of life (FACT
* Cog questionnaire, QoL score ≤ percentile 10 by age),
* Absence of major cognitive impairment preventing the performance of cognitive tests (compliance with the MoCA score threshold according to the age and educational level of the patient according to GRECOGVASC standards)
* Absence of personality disorders and known progressive psychiatric pathology (e.g. schizophrenia),
* Absence of symptomatic neurological history (neurological sequelae of a head trauma, stroke with loss of consciousness\> 30 min, multiple sclerosis, epilepsy, neurodegenerative pathology, etc.),
* Patient with level of education 3 "end of primary education" minimum (Barbizet scale),
* Have access to a computer (fixed or portable) equipped with a keyboard, a webcam (or the possibility of connecting one), headphones or speakers; have an internet connection and an e-mail account; be able to use these tools and Equipment,
* Mastery of the French language,
* Patient who signed the consent to participate in the study.
* Patients should start the study during radiation therapy.
Exclusion Criteria
* Severe visual and / or hearing loss,
* Patient unable to respond to cognitive tests,
* Medical contraindication to the practice of adapted physical activity
* Cognitive management in progress,
* Patient's refusal to participate,
* Patient deprived of liberty or under guardianship,
* Patient unable to submit to study monitoring for geographic, social or psychopathological reasons.
18 Months
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute, France
OTHER_GOV
Ligue contre le cancer, France
OTHER
Centre Francois Baclesse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
centre François Baclesse
Caen, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Binarelli G, Joly F, Christy F, Clarisse B, Lange M. Digital multimodal intervention for cancer-related cognitive impairment in breast-cancer patients: Cog-Stim feasibility study. BMC Psychiatry. 2025 Mar 17;25(1):249. doi: 10.1186/s12888-025-06630-9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A02500-57
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.